[ Price : $8.95]
FDA approves Bristol Myers Squibbs combination of Opdivo (nivolumab) with Yervoy (ipilimumab) for treating certain adult and pedia...[ Price : $8.95]
FDA warns Lawrenceville, NJ-based EpiCare Acquisitions about Quality System and other violations in its manufacturing of a family ...[ Price : $8.95]
Bausch + Lomb recalls its enVista intraocular lenses after the company received reports of complications, which it says could not ...[ Price : $8.95]
Six Sidley attorneys raise several practical questions arising from a Texas federal court decision finding that FDA does not have ...[ Price : $8.95]
FDA grants Allogene Therapeutics three fast track designations for ALLO-329, an investigational dual-targeted CD19/CD70 allogeneic...[ Price : $8.95]
A Senate HELP Committee postpones a hearing tentatively planned for 4/10 because HHS secretary Robert F. Kennedy, Jr. reportedly c...[ Price : $8.95]
Rhythm Pharmaceuticals announces positive topline results from the pivotal Phase 3 TRANSCEND trial evaluating setmelanotide for tr...[ Price : $8.95]
FDA accepts for review a Teva Pharmaceuticals supplemental BLA for Ajovy (fremanezumab-vfrm) to expand the indication to include p...